Picture of Biocon logo

BIOCON Biocon Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Biocon, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line10,0268,7098,5597,7166,430
Depreciation
Non-Cash Items2483,6922,0636,4238,260
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-3,206-5,092-6,514-10,177-7,296
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities11,54612,83111,25912,10418,525
Capital Expenditures-14,920-18,365-17,463-19,248-17,263
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items7,7822,776-18,7842,257-125,555
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-7,138-15,589-36,247-16,991-142,818
Financing Cash Flow Items-1,007-937-1,160-1,096-4,856
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,4173,87625,6402,421130,487
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,1031,654723-2,4336,411